-
Attending the
#BiotechShowcase today? Our Director of Business Development, Mansi Joshi, is on the ground and is excited to network and showcase our#AI-powered platform,#AlphaMeld.@EBDgroup#JPMorgan#JPMWeek#BioWeekSF#Innovation#Biotech#AI#MLpic.twitter.com/QR3EWLwk6b
-
Good morning
#SanFrancisco! Come meet our CEO, Krishnan Nandabalan, and the rest of team InveniAI at the@JPMorgan#Healthcare Conference to learn more about how our innovative#AlphaMeld platform can benefit your clinical pipeline!#JPM2020#JPMWeek#BioWeekSF#AI#Innovationpic.twitter.com/AndgsNGPZ1
-
Our CEO, Krishnan Nandabalan, sat down with
@moealsumidaie and discussed how#AI and#ML can transform the#ClinicalTrial process. Read the full article here: http://bit.ly/2YR3Ra2#ArtificialIntelligence#MachineLearning#Oncology#Healthcare#IoT#AlphaMeld#FindYourAlpha -
Day 1 at
@BIOConvention. Meet us to explore our unique#ArtificialIntelligence platforms (#AlphaMeld &#EvolverAI) and discuss partnering opportunities.#BIO2018#MakingBIOHistory#ChampionsofScience pic.twitter.com/JlixGcERzP
-
Our CEO, Krishnan Nandabalan, in action at the P-D-R Annual Meeting, answering questions about
#AI in the 'hot seat' challenge!#FindYourAlpha#PDR#Technology#Biopharma#AlphaMeld#Presentation#ML#CIpic.twitter.com/IJ5dvIdQ5m
-
#AlphaMeld® has assigned@Regeneron's REGN 5458, a Phase 1 drug in development for the treatment of#MultipleMyeloma, with a 96% probability to progress to the next stage.#WorldCancerDay
#Cancer#PredictiveAnalytics Contact us at info@inveniai.com to schedule a demo.pic.twitter.com/jaBqi1c4ym
-
Team InveniAI is looking forward to attending
#JPM2020 and the#BiotechShowcase next week! If you are attending and interested in learning more about InveniAI and#AlphaMeld®, please contact us at solutions@inveniai.com. -
Over 2.5 quintillion bytes of data are created daily. Finding anything of worth in that jumble of data is like trying to find a white cat in a snowstorm. This is where our
#AI and#ML platform,#AlphaMeld, can lend a hand.#FindYourAlpha Listen here
:http://bit.ly/2DHwhqu
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.